[ad_1] (Part four of a four-part series – Read part three) The reason why companies offering psychedelic-assisted therapy only use ketamine is that at the moment it is the only one…
[ad_1] UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing the total to date up to $2.437.750 (£2.5 million), all of which will be used…
[ad_1] Educational platform training and certifying psychedelic therapists Fluence has been selected by Oregon’s Higher Education Coordinating Commission (HECC) and the Oregon Health Authority (OHA) to be a state-licensed provider…
[ad_1] Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy As of January 2023, Canada’s 4th largest province will be the first to offer supervised treatments involving psychedelic substances…
[ad_1] Ontario-based producer of functional mushroom home grow kits and premium magic truffles Red Light Holland Corp. TRUFF has acquired MiniChamp B.V., a dutch home grow mushroom farm, through its…
[ad_1] A recent poll, led by University of Maine professors R. Glover and K. Sporer during July and August 2021 and shared this week, found that of the 400+ Mainers, a…
[ad_1] In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings. The emerging biotech BetterLife Pharma Inc. BETRF has filed an international PCT along…
[ad_1] Developmental-stage biopharma company Silo Pharma Inc. SILO announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $5.00 per share, to begin trading…
[ad_1] Origin Therapeutics Holdings Inc. ORIG, a psychedelics industry-focused investment issuer, announced that one of its portfolio companies, Xpira Pharmaceuticals, has obtained approval from the FDA for its first Investigational New Drug (IND) application for a Phase…
[ad_1] Biomind Labs Inc. BMNDF, a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of DMT-based proprietary…
[ad_1] Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. AWKNF has announced its financial outcomes and business highlights for the three months ended July 31,…
[ad_1] Canadian-based psychedelics company Nova Mentis Life Science Corp. NMLSF, or NOVA, is collaborating with the Toronto Institute of Pharmaceutical Technology (TIPT), a Health Canada-licensed GMP manufacturing and testing facility, to complete the…
[ad_1] HealingMaps, an informative psychedelic therapy search site, announced the closing of a seed round funding for a total $1 million coming from eight investors including Phyto Partners and Ambria…
[ad_1] Oregon voters said yes to all-psychedelics possession decriminalization in 2020’s state ballot, and a recent poll by Data for Progress showed that the majorly stand by Measure 110’s original approval. The new…
[ad_1] Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. NUMIF recently acquired psychedelics company Novamind and is successfully integrating its activities: US clinics performed solidly…
[ad_1] In recent months, the psychedelics space has been ground for increasing collaborations. In some cases it was to advance scientific studies. In others, to offer psychedelic medicine, therapy training and…
[ad_1] Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on access needs for veterans. …
[ad_1] The growing demand for better treatments for mental health conditions is taking the discussion to the public sphere often than not. With San Francisco’s final call to decriminalize psychedelics last…
[ad_1] Nirvana Life Sciences Inc. NIRV announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds. The 3-step synthesis starts from the MDMA precursor safrole and takes only…
[ad_1] Expert functional and magic mushrooms grower Optimi Health Corp. OPTHF has signed an agreement with Avida Global, a privately-held UK-based producer of white label products including nutraceuticals and medicinal…
[ad_1] Psychedelics R&D company Mindset Pharma MSSTF has filed no less than 16 national applications, including countries within the main South East Asian markets, for one of its key families…
[ad_1] On Wednesday, a measure urging the local police to deprioritize psychedelics possession and consumption by adults was unanimously approved by the San Francisco Board of Supervisors. Originally introduced by supervisors Dean…
[ad_1] Psychedelic medicine is an issue increasingly visited by lawmakers, clinicians, researchers, patients and advocates at local, state and federal levels. This week, House Committees in both Missouri and Georgia heard…
[ad_1] Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. DRUG has closed its overnight offering for gross proceeds of approximately $4 million. The company also announced it will start dosing patients…
[ad_1] The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.…